Form 8-K - Current report:
SEC Accession No. 0000950123-96-001871
Filing Date
1996-04-26
Accepted
1996-04-26 00:00:00
Documents
2
Period of Report
1996-04-01
Items
Item 2: Acquisition or disposition of assets
Item 5: Other events
Item 7: Financial statements and exhibits
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT 8-K 10525
2 AGREEMENT AND PLAN OF MERGER DATED APRIL 11, 1996 EX-2.1 106471
  Complete submission text file 0000950123-96-001871.txt   118719
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
ONCOGENE SCIENCE INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 96551658
SIC: 2835 In Vitro & In Vivo Diagnostic Substances